- Home
- TLSI vs CURI Comparison
TLSI vs CURI Comparison
Compare TLSI & CURI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TLSI
- CURI
- Stock Information
- Founded
- TLSI 2010
- CURI N/A
- Country
- TLSI United States
- CURI United States
- Employees
- TLSI N/A
- CURI N/A
- Industry
- TLSI Medical Specialities
- CURI Movies/Entertainment
- Sector
- TLSI Health Care
- CURI Consumer Discretionary
- Exchange
- TLSI Nasdaq
- CURI Nasdaq
- Market Cap
- TLSI 244.3M
- CURI 264.7M
- IPO Year
- TLSI N/A
- CURI N/A
- Fundamental
- Price
- TLSI $4.73
- CURI $5.14
- Analyst Decision
- TLSI Strong Buy
- CURI Strong Buy
- Analyst Count
- TLSI 4
- CURI 3
- Target Price
- TLSI $11.13
- CURI $6.00
- AVG Volume (30 Days)
- TLSI 118.6K
- CURI 533.6K
- Earning Date
- TLSI 11-13-2025
- CURI 11-05-2025
- Dividend Yield
- TLSI N/A
- CURI 6.30%
- EPS Growth
- TLSI N/A
- CURI N/A
- EPS
- TLSI N/A
- CURI N/A
- Revenue
- TLSI $35,990,000.00
- CURI $60,840,000.00
- Revenue This Year
- TLSI $56.79
- CURI $34.86
- Revenue Next Year
- TLSI $54.15
- CURI $9.69
- P/E Ratio
- TLSI N/A
- CURI N/A
- Revenue Growth
- TLSI 45.50
- CURI 11.02
- 52 Week Low
- TLSI $3.42
- CURI $1.47
- 52 Week High
- TLSI $5.88
- CURI $7.15
- Technical
- Relative Strength Index (RSI)
- TLSI 48.36
- CURI 57.47
- Support Level
- TLSI $4.42
- CURI $4.95
- Resistance Level
- TLSI $4.67
- CURI $5.34
- Average True Range (ATR)
- TLSI 0.23
- CURI 0.27
- MACD
- TLSI -0.03
- CURI -0.01
- Stochastic Oscillator
- TLSI 61.87
- CURI 57.23
About TLSI TriSalus Life Sciences Inc.
TriSalus Life Sciences Inc is engaged in the research, development, and sales of drug delivery technology and immune-oncology therapeutics to improve outcomes in difficult-to-treat liver and pancreatic cancer. It is developing and marketing two product linesPressure Enabled Drug Delivery (PEDD) infusion systems, in use today, and an investigational agent, nelitolimod (SD-101), which shows potential to enhance immune system response in the treatment of hepatocellular cancer, pancreatic cancer and other liver solid tumors. TriNav is the newest therapy delivery device with SmartValve technology for the proprietary PEDD approach.
About CURI CuriosityStream Inc.
CuriosityStream Inc is a media and entertainment company. It offers premium video programming across the principal categories of factual entertainment, including science, history, society, nature, lifestyle, and technology. Its mission is to provide premium real entertainment that informs, enchants, and inspires. Its product and services are Direct to Consumer Business, Partner Direct Business, Bundled Distribution, Content Licensing, Enterprise Subscriptions and Others. The majority of the revenue comes from the Direct to direct-to-consumer business.